News
Developed a non-invasive test that identifies patients at risk of kidney transplant rejection
About 20% of kidney transplants are rejected by the patient
Live the science! From 14 to 23 November it is the Science Week
Opening Day at the Parliament of Catalonia
Researchers describe a mechanism that explains how the breast cancer cells transform normal cells into tumoral ones
The study opens the door to the development of biomarkers and therapeutic strategies What are exosomes? In human samples and in mice Article reference
Our brain dissociates emotional response from explicit memory in fearful situations
The study may explain why in some anxiety disorders or post-traumatic stress disorder the patient is unable to get to the root of the problem Article reference
Useful markers to predict response to chemotherapy in patients with liver cancer
Difficult treatment Resistence biomarkers Article reference
Alexandre Puerto, new IDIBELL Management Director
On September 3 Alexandre Puerto joined as the new IDIBELL Management Director. Mr. Puerto joins IDIBELL after being part of the IRB Barcelona, where he has directed for more than six years the Department of Finance and management and project justification. Previously, he has developed his career in multinationals in different sectors in Spain and […]
Mutua Madrileña Foundation funds a research project on personalized treatments in lung cancer
Award Ceremony of the XI Call for Research Grants of the Mutua Madrileña Foundation attended by Secretary of State for Research, Development and Innovation, Carmen Vela was held last October 10. The team leader of the ICO-IDIBELL chemoresistance research group, Alberto Villanueva, has received 41,000 euros to finance a project aimed at personalizing lung cancer. […]